Anti-PD1
IRB NO. 202400085B0
Unknown small_molecule completed
Quick answer
Anti-PD1 for Nasopharyngeal Carcinoma (NPC) is a Unknown program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Nasopharyngeal Carcinoma (NPC)
- Phase
- Unknown
- Modality
- small_molecule
- Status
- completed